 or other biologic factors
that accurately measure the lifelong risk for development of an aortic aneurysm; (2) to discover pharmacologic agents to limit aneurysm enlargement; (3) to
characterize biomarkers or imaging-derived determinants of rupture risk; (4) to design prostheses that resist
infection and thrombosis; (5) to develop tools, intraoperative imaging or robotic systems, and improved endovascular grafts that facilitate repair in